Table 1.
Association of RUNX2 expression with clinicopathological features of epithelial ovarian cancer tissues.
| Features | No. of patients | RUNX2 expression (n, %) | P | |
|---|---|---|---|---|
| Low | High | |||
| Age | ||||
| <50 | 48 | 16 (33.3) | 32 (66.7) | 0.69 |
| ≥50 | 68 | 22 (32.4) | 46 (67.6) | |
| Clinial stage | ||||
| I~II | 26 | 18 (69.2) | 8 (30.8) | 0.001 |
| III~IV | 90 | 20 (22.2) | 70 (77.8) | |
| Pathological grade | ||||
| 1~2 | 33 | 15 (45.5) | 18 (54.5) | 0.06 |
| 3 | 83 | 23 (27.7) | 60 (72.3) | |
| Histological type | ||||
| Serous | 88 | 28 (31.2) | 60 (68.8) | 0.57 |
| Non-serous | 28 | 10 (35.7) | 18 (64.3) | |
| Residual tumor after surgery | ||||
| <1 cm | 66 | 23 (34.8) | 43 (65.2) | 0.51 |
| ≥1 cm | 50 | 15 (30.0) | 35 (70.0) | |